NuVasive and Siemens Form Partnership

NuVasive Inc. said Aug. 9 that it has formed a strategic partnership with Germany-based Siemens Healthineers.

Walk-In Clinics Part Of Care Providers’ Pursuit of Patients

MEDICINE: Bringing Services to the Consumer Is Trend in Health Care

Forget far-off appointments and long drives to the doctor’s office.

Tease photo

Reporter’s Notebook: Politics and Priorities Hinder Repeal of Medical Device Tax

Competing congressional priorities are clouding the path forward for an effort to kill a 2.3 percent excise tax on medical device makers, San Diego’s NuVasive and ResMed among them.

Samumed, San Diego Biotech Developing Regenerative Drugs, Announces $438M Financing Round

Company is developing treatments for a broad range of diseases, including a variety of cancers and Alzheimer’s.

AMN Reports Record Quarterly Revenue

AMN Healthcare Services Inc., the San Diego-based health care staffing company, reported net income of $35.5 million on revenue of $558.1 million in the second quarter of 2018.

#7 Fastest Growing Private Company

Special Report: Fastest-Growing Private Companies

It was his own battle with obesity that lead Drew Canole, founder of Organifi, down a path of educating others about making healthy choices and living healthy lives.

Tease photo

Q2: Strong Ingrezza Sales Lift Neurocrine

Neurocrine’s Ingrezza — the first treatment for the nervous system disorder tardive dyskinesia — continues to rake in revenue.

Q4: ResMed Revenue Up 12 Percent

San Diego-based ResMed listed fourth quarter revenue as $623.6 million, a 12 percent year-over-year increase.

Dexcom’s Stock Soars After Q2 Results

San Diego-based Dexcom’s stock hit $118.57 a share the morning of Aug. 2, up sharply from closing Aug. 1 at $95.44.

Q2: NuVasive Revenue Jumps 8.5%

San Diego medical device company NuVasive reported $281.6 million in second quarter earnings, an 8.5 percent year-over-year jump.

Omniome Raises $60M Round

San Diego-based Omniome, maker of a DNA sequencing platform, today announced a $60 million series B round.

Illumina’s Q2 Revenue, Earnings Beat Expectations

Illumina in the second quarter reported revenue of $830 million, a 25 percent year-over-year increase.

Irish Drug Company Sublimity Opens Solana Beach Office

Sublimity Therapeutics, an Irish pharmaceutical in the realm of gastrointestinal and immunological diseases, has set up a Solana Beach office with six employees.

Gossamer May Give S.D. Its Flagship Biotech

PHARMA: A $230M Funding Round, Strong Leaders Are Big Pluses

By going big, Gossamer Bio looks to break the mold.

Tease photo

Mesa Biotech Picks up $20M Series B Round

Molecular diagnostic company Mesa Biotech recently notched a $20 million series B round.